vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Valens Semiconductor Ltd. (VLN). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $17.3M, roughly 1.4× Valens Semiconductor Ltd.). Valens Semiconductor Ltd. runs the higher net margin — -42.2% vs -54.6%, a 12.3% gap on every dollar of revenue. Valens Semiconductor Ltd. produced more free cash flow last quarter ($-4.9M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Valens Semiconductor (Valens) is an Israeli fabless manufacturing company providing semiconductors for the automotive and audio-video industries. Valens provides semiconductor products for the distribution of uncompressed ultra-high-definition (UHD) multimedia content and in-vehicle connectivity applications. The company is a member of the MIPI Alliance and developed the first-to-market chipset that is compliant with the MIPI A-PHY standard. Valens invented the technology behind the HDBaseT s...
CBLL vs VLN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $17.3M |
| Net Profit | $-13.5M | $-7.3M |
| Gross Margin | 87.3% | 63.0% |
| Operating Margin | -58.9% | -46.4% |
| Net Margin | -54.6% | -42.2% |
| Revenue YoY | — | 8.1% |
| Net Profit YoY | — | 29.3% |
| EPS (diluted) | $-0.35 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | — | ||
| Q3 25 | $22.6M | $17.3M | ||
| Q2 25 | $21.2M | $17.1M | ||
| Q1 25 | $20.5M | $16.8M | ||
| Q3 24 | $17.2M | $16.0M | ||
| Q2 24 | — | $13.6M | ||
| Q2 23 | — | $24.2M | ||
| Q2 22 | — | $22.5M |
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $-7.3M | ||
| Q2 25 | $-13.6M | $-7.2M | ||
| Q1 25 | $-12.8M | $-8.3M | ||
| Q3 24 | $-10.4M | $-10.4M | ||
| Q2 24 | — | $-8.9M | ||
| Q2 23 | — | $-4.6M | ||
| Q2 22 | — | $-10.0M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | 63.0% | ||
| Q2 25 | 88.1% | 63.5% | ||
| Q1 25 | 87.9% | 62.9% | ||
| Q3 24 | 87.3% | 56.4% | ||
| Q2 24 | — | 61.4% | ||
| Q2 23 | — | 61.8% | ||
| Q2 22 | — | 70.2% |
| Q4 25 | -58.9% | — | ||
| Q3 25 | -64.8% | -46.4% | ||
| Q2 25 | -70.5% | -43.3% | ||
| Q1 25 | -69.3% | -56.2% | ||
| Q3 24 | -57.8% | -76.3% | ||
| Q2 24 | — | -69.2% | ||
| Q2 23 | — | -21.4% | ||
| Q2 22 | — | -35.3% |
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | -42.2% | ||
| Q2 25 | -64.4% | -42.1% | ||
| Q1 25 | -62.4% | -49.4% | ||
| Q3 24 | -60.6% | -64.6% | ||
| Q2 24 | — | -65.2% | ||
| Q2 23 | — | -19.0% | ||
| Q2 22 | — | -44.5% |
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $-0.37 | $-0.07 | ||
| Q2 25 | $-0.38 | $-0.07 | ||
| Q1 25 | $-0.36 | $-0.08 | ||
| Q3 24 | $-1.85 | $-0.10 | ||
| Q2 24 | — | $-0.08 | ||
| Q2 23 | — | $-0.05 | ||
| Q2 22 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $93.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $108.8M |
| Total Assets | $195.8M | $136.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | $93.5M | ||
| Q2 25 | $177.4M | $102.7M | ||
| Q1 25 | $182.7M | $112.5M | ||
| Q3 24 | $14.1M | $133.1M | ||
| Q2 24 | — | $105.9M | ||
| Q2 23 | — | $138.0M | ||
| Q2 22 | — | $46.6M |
| Q4 25 | $155.3M | — | ||
| Q3 25 | $164.1M | $108.8M | ||
| Q2 25 | $172.2M | $116.5M | ||
| Q1 25 | $180.9M | $128.6M | ||
| Q3 24 | $-136.0M | $147.0M | ||
| Q2 24 | — | $153.5M | ||
| Q2 23 | — | $166.3M | ||
| Q2 22 | — | $173.2M |
| Q4 25 | $195.8M | — | ||
| Q3 25 | $199.5M | $136.7M | ||
| Q2 25 | $207.7M | $144.8M | ||
| Q1 25 | $213.5M | $154.6M | ||
| Q3 24 | $47.1M | $171.9M | ||
| Q2 24 | — | $175.8M | ||
| Q2 23 | — | $184.3M | ||
| Q2 22 | — | $196.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $-4.7M |
| Free Cash FlowOCF − Capex | $-11.0M | $-4.9M |
| FCF MarginFCF / Revenue | -44.2% | -28.5% |
| Capex IntensityCapex / Revenue | 0.7% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | $-11.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | — | ||
| Q3 25 | $-11.1M | $-4.7M | ||
| Q2 25 | $-7.5M | $-211.0K | ||
| Q1 25 | $-11.4M | $-7.6M | ||
| Q3 24 | — | $3.0M | ||
| Q2 24 | — | $-225.0K | ||
| Q2 23 | — | $358.0K | ||
| Q2 22 | — | $-4.3M |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | $-4.9M | ||
| Q2 25 | $-7.6M | $-330.0K | ||
| Q1 25 | $-11.6M | $-8.0M | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $-460.0K | ||
| Q2 23 | — | $-419.0K | ||
| Q2 22 | — | $-4.5M |
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | -28.5% | ||
| Q2 25 | -35.9% | -1.9% | ||
| Q1 25 | -56.4% | -47.3% | ||
| Q3 24 | — | 14.0% | ||
| Q2 24 | — | -3.4% | ||
| Q2 23 | — | -1.7% | ||
| Q2 22 | — | -20.0% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | 1.6% | ||
| Q2 25 | 0.3% | 0.7% | ||
| Q1 25 | 0.7% | 2.1% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 1.7% | ||
| Q2 23 | — | 3.2% | ||
| Q2 22 | — | 1.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
VLN
Segment breakdown not available.
